This is the most important caveat for beginners, and the one most vendor pages omit
The Endocrine Society's 2019 clinical practice guideline on GH deficiency states that GH therapy in adults should be initiated only after confirmation of GHD by stimulation testing and should target IGF-1 to the age-adjusted mid-normal range
For inflammatory bowel disease, mesalamine, corticosteroids, immunomodulators (azathioprine, methotrexate), and biologics (infliximab, adalimumab, vedolizumab, ustekinumab) all have Level 1 evidence from Phase III trials with thousands of patients
The main reason is that GSH-Au NCs@His does not have the capacity to form an Au-S bond, which greatly reduces the effectiveness of GSH-Au NCs@His to consume GSH, thus protecting tumor cells from ROS oxidative damage (Figure 7C)